Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

No reported Net Receivables figures are available to summarize.

Net Receivables history

Currency unavailable · from the balance sheet

No Net Receivables data reported for this period type.

Net Receivables vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Net Receivables for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANABAnaptysBio, Inc.Mar 2026$25.75M USD+44.0%+187.9%7.8%
PTGXProtagonist Therapeutics, Inc.Jun 2026$13.42M USD-52.0%+342.2%1.5%
ACRSAclaris Therapeutics, Inc.Mar 2026$4.81M USD+1825.6%+125.7%2.4%
ALMSAlumis Inc. Common StockJun 2026$3.86M USD-50.9%+60.9%0.7%
IMUXImmunic, Inc.Mar 2026$354K USD-43.9%+140.6%0.2%
SYRESpyre Therapeutics, Inc.Sep 2026$0 USD——0.0%
ORKAOruka Therapeutics, Inc.Sep 2026$0 USD——0.0%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€0 EUR——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-43.9%+140.6%0.4%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.